BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kissin E, Korn JH. Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Curr Rheumatol Rep 2002;4:129-35. [PMID: 11890878 DOI: 10.1007/s11926-002-0008-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Denton CP, Lindahl GE, Khan K, Shiwen X, Ong VH, Gaspar NJ, Lazaridis K, Edwards DR, Leask A, Eastwood M, Leoni P, Renzoni EA, Bou Gharios G, Abraham DJ, Black CM. Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-β Receptor (TβRIIΔk). Journal of Biological Chemistry 2005;280:16053-65. [DOI: 10.1074/jbc.m413134200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
2 Boric K, Mardesic S, Martinovic Kaliterna D, Radic M, Tadin Hadjina I, Vukojevic K, Kosovic I, Solic I, Zekic Tomas S, Saraga-Babic M. Expression of apoptotic and proliferation factors in gastric mucosa of patients with systemic sclerosis correlates with form of the disease. Sci Rep 2019;9:18461. [PMID: 31804582 DOI: 10.1038/s41598-019-54988-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Pines M, Snyder D, Yarkoni S, Nagler A. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant. 2003;9:417-425. [PMID: 12869955 DOI: 10.1016/s1083-8791(03)00151-4] [Cited by in Crossref: 132] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
4 Kozlova A, Pachera E, Maurer B, Jüngel A, Distler JHW, Kania G, Distler O. Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis. Arthritis Rheumatol 2019;71:2068-80. [PMID: 31309742 DOI: 10.1002/art.41041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Villano M, Borghini A, Manetti M, Gabbrielli E, Rossi A, Sestini P, Milia A, Nacci F, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L, Weber E. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide. Arthritis Res Ther 2013;15:R90. [PMID: 23962393 DOI: 10.1186/ar4270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Gruber BL. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 2003;5:147-53. [PMID: 12628046 DOI: 10.1007/s11926-003-0043-3] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
7 Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum 2006;54:3655-60. [PMID: 17075814 DOI: 10.1002/art.22186] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
8 Laplante P, Raymond MA, Gagnon G, Vigneault N, Sasseville AM, Langelier Y, Bernard M, Raymond Y, Hébert MJ. Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J Immunol 2005;174:5740-9. [PMID: 15843576 DOI: 10.4049/jimmunol.174.9.5740] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 5.3] [Reference Citation Analysis]
9 Monument MJ, Hart DA, Salo PT, Befus AD, Hildebrand KA. Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions. Adv Wound Care (New Rochelle) 2015;4:137-51. [PMID: 25785237 DOI: 10.1089/wound.2013.0509] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
10 Giovanini AF, Gonzaga CC, Zielak JC, Deliberador TM, Kuczera J, Göringher I, de Oliveira Filho MA, Baratto-filho F, Urban CA. Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen III and α-smooth muscle actin: CRANIOFACIAL BONE REPAIR. J Orthop Res 2011;29:457-63. [DOI: 10.1002/jor.21263] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
11 Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, Gonzalez-cadavid NF. Evidence That Osteogenic Progenitor Cells in the Human Tunica Albuginea May Originate from Stem Cells: Implications for Peyronie Disease1. Biology of Reproduction 2005;73:1199-210. [DOI: 10.1095/biolreprod.105.041038] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
12 Jun JB, Kuechle M, Min J, Shim SC, Kim G, Montenegro V, Korn JH, Elkon KB. Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ. J Invest Dermatol 2005;124:298-303. [PMID: 15675946 DOI: 10.1111/j.0022-202X.2004.23559.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
13 Samuel CS. Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res 2005;3:241-9. [PMID: 16303890 DOI: 10.3121/cmr.3.4.241] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
14 Bogatkevich GS, Gustilo E, Oates JC, Feghali-Bostwick C, Harley RA, Silver RM, Ludwicka-Bradley A. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol 2005;288:L190-201. [PMID: 15447940 DOI: 10.1152/ajplung.00448.2003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
15 Davis J, Molkentin JD. Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol 2014;70:9-18. [PMID: 24189039 DOI: 10.1016/j.yjmcc.2013.10.019] [Cited by in Crossref: 177] [Cited by in F6Publishing: 168] [Article Influence: 22.1] [Reference Citation Analysis]
16 Flavahan NA, Flavahan S, Mitra S, Chotani MA. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheumatic Disease Clinics of North America 2003;29:275-91. [DOI: 10.1016/s0889-857x(03)00021-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
17 Barzilai A, Lyakhovitsky A, Horowitz A, Trau H. Keloid-like Scleroderma: . The American Journal of Dermatopathology 2003;25:327-30. [DOI: 10.1097/00000372-200308000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP, Vanpelt CS, Geng YJ, Deng JM, Behringer RR, de Crombrugghe B. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum. 2007;56:334-344. [PMID: 17195237 DOI: 10.1002/art.22328] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 9.5] [Reference Citation Analysis]
19 Giovanini AF, Leonardi DP, Baratto-Filho F, Vlença PC, Moresca RC, Moro A, Schramm CA. An endodontic sealer induces a pathological condition when associated with persistent tissue toxicity and presence of myofibroblasts. Braz Dent J 2011;22:369-76. [PMID: 22011891 DOI: 10.1590/s0103-64402011000500004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Tian J, An X, Niu L. Myocardial fibrosis in congenital and pediatric heart disease. Exp Ther Med 2017;13:1660-4. [PMID: 28565750 DOI: 10.3892/etm.2017.4224] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
21 Jafarinejad-Farsangi S, Farazmand A, Mahmoudi M, Gharibdoost F, Karimizadeh E, Noorbakhsh F, Faridani H, Jamshidi AR. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 2015;48:369-78. [PMID: 25857445 DOI: 10.3109/08916934.2015.1030616] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
22 Karimizadeh E, Motamed N, Mahmoudi M, Jafarinejad-Farsangi S, Jamshidi A, Faridani H, Gharibdoost F. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts. Arch Dermatol Res 2015;307:135-42. [PMID: 25527259 DOI: 10.1007/s00403-014-1532-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
23 Jafarinejad-Farsangi S, Farazmand A, Gharibdoost F, Karimizadeh E, Noorbakhsh F, Faridani H, Mahmoudi M, Jamshidi AR. Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis. Int J Dermatol 2016;55:1259-67. [PMID: 27637490 DOI: 10.1111/ijd.13308] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
24 Naik-Mathuria B, Pilling D, Crawford JR, Gay AN, Smith CW, Gomer RH, Olutoye OO. Serum amyloid P inhibits dermal wound healing. Wound Repair Regen 2008;16:266-73. [PMID: 18318811 DOI: 10.1111/j.1524-475X.2008.00366.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
25 Szabo I, Muntean L, Crisan T, Rednic V, Sirbe C, Rednic S. Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs. Biomedicines 2021;9:1471. [PMID: 34680587 DOI: 10.3390/biomedicines9101471] [Reference Citation Analysis]
26 Lord MS, Melrose J, Day AJ, Whitelock JM. The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology. J Histochem Cytochem 2020;68:907-27. [PMID: 32639183 DOI: 10.1369/0022155420940067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]